GBS (GBS) Competitors $1.55 +0.03 (+1.97%) As of 09/5/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock GBS vs. CTCX, TMDIF, HSAQ, RVP, PETV, BTCY, IVF, DYNT, IONM, and TTOOShould you be buying GBS stock or one of its competitors? The main competitors of GBS include Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), PetVivo (PETV), Biotricity (BTCY), INVO Fertility (IVF), Dynatronics (DYNT), Assure (IONM), and T2 Biosystems (TTOO). These companies are all part of the "surgical & medical instruments" industry. GBS vs. Its Competitors Carmell Titan Medical Health Sciences Acquisitions Co. 2 Retractable Technologies PetVivo Biotricity INVO Fertility Dynatronics Assure T2 Biosystems GBS (NYSE:GBS) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability. Which has higher earnings and valuation, GBS or CTCX? GBS has higher earnings, but lower revenue than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGBSN/AN/A-$8.31M-$0.56-2.77Carmell$32.84K1,546.92-$15.44MN/AN/A Does the media refer more to GBS or CTCX? In the previous week, GBS had 5 more articles in the media than Carmell. MarketBeat recorded 5 mentions for GBS and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 beat GBS's score of -0.27 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment GBS Neutral Carmell Neutral Do institutionals & insiders believe in GBS or CTCX? 2.8% of GBS shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 0.3% of GBS shares are held by insiders. Comparatively, 29.0% of Carmell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, GBS or CTCX? GBS has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Is GBS or CTCX more profitable? GBS's return on equity of -85.64% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets GBSN/A -85.64% -54.42% Carmell N/A -217.50%-50.22% SummaryCarmell beats GBS on 5 of the 9 factors compared between the two stocks. Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$23.08M$77.48M$5.81B$21.38BDividend YieldN/AN/A6.70%3.49%P/E Ratio-2.7710.9675.9129.64Price / SalesN/A94.76475.5548.98Price / CashN/A18.4125.7018.12Price / Book3.5212.2611.904.59Net Income-$8.31M-$26.39M$3.28B$999.86M7 Day Performance-4.32%6.16%0.99%1.13%1 Month Performance1.97%5.19%10.64%5.61%1 Year Performance-1.90%92.33%65.62%16.98% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.55+2.0%N/A-1.9%$23.08MN/A-2.777CTCXCarmellN/A$2.54-1.6%N/A+415.3%$53.09M$32.84K0.0014TMDIFTitan MedicalN/A$0.32flatN/A+776.4%$36.70M$17.63M-0.2650Gap UpHSAQHealth Sciences Acquisitions Co. 2N/A$2.73+0.7%N/A-51.0%$30.61MN/A0.004RVPRetractable Technologies2.6294 of 5 stars$0.80-4.5%N/A-14.4%$23.95M$38.16M-1.48240News CoverageShort Interest ↓PETVPetVivoN/A$0.79-6.5%N/A+19.1%$22.18M$1.05M-1.7720Gap DownBTCYBiotricityN/A$0.58+7.2%N/A+83.6%$14.42M$12.06M-0.5440Gap DownIVFINVO FertilityN/A$0.92-3.7%N/A-96.3%$4.19M$6.53M-0.0125Positive NewsDYNTDynatronicsN/A$0.09-1.6%N/A-45.3%$1.18M$33.60M-0.11200Gap DownIONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130TTOOT2 BiosystemsN/A$0.00+2.5%N/A-99.6%$86K$7.68M0.00180Gap Up Related Companies and Tools Related Companies Carmell Alternatives Titan Medical Alternatives Health Sciences Acquisitions Co. 2 Alternatives Retractable Technologies Alternatives PetVivo Alternatives Biotricity Alternatives INVO Fertility Alternatives Dynatronics Alternatives Assure Alternatives T2 Biosystems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GBS) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBS Stock Alerts